Literature DB >> 24759800

Tyrosine phosphorylation of β-catenin affects its subcellular localization and transcriptional activity of β-catenin in Hela and Bcap-37 cells.

He-Ya Qian1, Ding-Guo Zhang1, Hong-Wei Wang1, Dong-Sheng Pei2, Jun-Nian Zheng3.   

Abstract

In order to investigate the relationship between tyrosine phosphorylation of β-catenin and transcriptional activity of β-catenin in Hela and Bcap-37 cells, genistein (a tyrosine kinase inhibitor) was used to inhibit tyrosine phosphorylation in cells. Our results showed the total β-catenin protein levels were mainly equal in Hela, Bcap-37 and HK-2 cells, β-catenin was mainly present in nucleus in Hela and Bcap-37cells, while in HK-2 cell β-catenin was mainly located in cytoplasm. Genistein could inhibit tyrosine phosphorylation of β-catenin and downregulate nuclear β-catenin expression in Hela and Bcap-37 cells. In addition, genistein suppressed Ki-67 promoter activity and Ki-67 protein level, thus promoted cell apoptosis. Furthermore, β-catenin could increase the Ki-67 promoter activity in Hela and Bcap-37 cells. From these findings we conclude that tyrosine phosphorylation of β-catenin can regulate the cellular distribution of β-catenin and affect the transcriptional activity of β-catenin.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genistein; Ki-67; Tyrosine phosphorylation; β-Catenin

Mesh:

Substances:

Year:  2014        PMID: 24759800     DOI: 10.1016/j.bmcl.2014.03.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Phosphorylation of SNAP-23 regulates its dynamic membrane association during mast cell exocytosis.

Authors:  Pieu Naskar; Niti Puri
Journal:  Biol Open       Date:  2017-09-15       Impact factor: 2.422

2.  Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway.

Authors:  Linlin Huang; Ertao Zhai; Shirong Cai; Yi Lin; Junbin Liao; Huilin Jin; Sui Peng; Lixia Xu; Minhu Chen; Zhirong Zeng
Journal:  J Exp Clin Cancer Res       Date:  2018-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.